Back

Lipoprotein(a) and cardiovascular risk scores (HEART- / ASCVD) in primary prevention

12 April 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention – Cardiovascular Risk Assessment Scores EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Marcus Etienne Moellenberg

Lung Centre, Schmallenberg (Germany)

45 More presentations in this session

Presentation thumbnail
Professor A. Oulhaj (Abu Dhabi, AE)
Abstract
Presentation thumbnail
Doctor J. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Ms S. Denissen (Rotterdam, NL)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor N. Georgieva (Sofia, BG)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention – Cardiovascular Risk Assessment

The Event

Event poster

EuroPrevent 2019

12 April 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
7 October 2025
thumbnail
Congress Presentation
Aspirin use for prevention of cardiovascular events in patients with high lipoprotein(a): a population-based study
3 September 2019
thumbnail
Congress Presentation
Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study
3 April 2025
thumbnail
Congress Presentation
The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources